<p>Liver tumors exhibit significant heterogeneity in etiology, pathology, and treatment response, making accurate differential diagnosis critical for diagnosis and management. While multi-phase contrast-enhanced computed tomography (CT) provides valuable imaging patterns for differentiation, visual assessment alone is often limited by overlapping features. To address this, we present MCT-LTDiag, a comprehensive Multi-phase CT dataset for Liver Tumor Diagnosis, comprising 517 cases with four-phase contrast-enhanced&#xa0;CT scans (non-contrast, arterial, portal venous, and delayed phases) and five tumor subtypes: hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), colorectal liver metastasis (CRLM), breast cancer liver metastasis (BCLM), and hepatic hemangioma (HH). The dataset features standardized preprocessing, rigorous quality control, and expert-annotated tumor masks. Baseline experiments using radiomics-based machine learning and deep learning models demonstrate the dataset’s utility, with multi-phase integration significantly improving diagnostic performance. MCT-LTDiag serves as a benchmark for advancing automated liver tumor subtype classification and is publicly available to support future research.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

A Multi-phase CT Dataset for Automated Differential Diagnosis of Liver Tumors

  • Xiang´an Wu,
  • Haoyang Su,
  • Yiwei Hua,
  • Yali Xu,
  • Lilong Wang,
  • Xiaosong Wang,
  • Shitian Wang,
  • Bao Jin,
  • Xiao Liu,
  • Xueshuai Wan,
  • Qiang Sun,
  • Xuan Wang,
  • Shunda Du

摘要

Liver tumors exhibit significant heterogeneity in etiology, pathology, and treatment response, making accurate differential diagnosis critical for diagnosis and management. While multi-phase contrast-enhanced computed tomography (CT) provides valuable imaging patterns for differentiation, visual assessment alone is often limited by overlapping features. To address this, we present MCT-LTDiag, a comprehensive Multi-phase CT dataset for Liver Tumor Diagnosis, comprising 517 cases with four-phase contrast-enhanced CT scans (non-contrast, arterial, portal venous, and delayed phases) and five tumor subtypes: hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), colorectal liver metastasis (CRLM), breast cancer liver metastasis (BCLM), and hepatic hemangioma (HH). The dataset features standardized preprocessing, rigorous quality control, and expert-annotated tumor masks. Baseline experiments using radiomics-based machine learning and deep learning models demonstrate the dataset’s utility, with multi-phase integration significantly improving diagnostic performance. MCT-LTDiag serves as a benchmark for advancing automated liver tumor subtype classification and is publicly available to support future research.